A Step Ahead in Transcatheter Mitral Valve Repair

OUR CONCEPT

Vision

100% of affected patients to be treated

Mission

Respect versus resect

Serving Patients

Broadening transcatheter innovation to better serve options for renewing patients' lives

WHAT WE DO

Problem

More than 8 million people in Europe and the US suffer from mitral regurgitation (blood leaking back into the heart´s left atrium). If left untreated, this condition may ultimately lead to heart failure.

State Of The Art

Open-heart surgery is the current gold-standard for treating mitral valve prolapse. As this procedure bears significant risks for the patients, up to 50% of the affected population are left untreated.

Solution

Our Mitral Butterfly implant is based on an individually adaptable design, guaranteeing closure of the valve´s leaflets. Its transcatheter implantation provides a low-risk, minimally invasive procedure.

WHO WE ARE

 

Prof. Werner Mohl

Founder

 

Johanna Maria Ticar

R&D Project manager

 

Olga Górna

R&D Engineer

 

Arpad Bakonyi

CAD Engineer